{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T21:04:47Z","timestamp":1794258287169,"version":"4.9.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jiac.2026.103054","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:11:29Z","timestamp":1787008289000},"page":"103054","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical improvement of methicillin-resistant Staphylococcus epidermidis prosthetic knee joint infection after changing therapy from tedizolid to linezolid: A case report"],"prefix":"10.1016","volume":"32","author":[{"given":"Yuichi","family":"Shibata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Asai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taketo","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Hagihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takkan","family":"Morishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobunori","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8876-6411","authenticated-orcid":false,"given":"Hiroshige","family":"Mikamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2026.103054_bib1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ocl.2023.09.002","article-title":"Recurrent periprosthetic joint infections: diagnosis, management, and outcomes","volume":"55","author":"Deans","year":"2024","journal-title":"Orthop Clin N Am"},{"key":"10.1016\/j.jiac.2026.103054_bib2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cis803","article-title":"Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the infectious diseases society of America","volume":"56","author":"Osmon","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2026.103054_bib3","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/CMR.00111-13","article-title":"Prosthetic joint infection","volume":"27","author":"Tande","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jiac.2026.103054_bib4","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jinf.2022.07.009","article-title":"Epidemiology and antibiotic resistance of prosthetic joint infections according to time of occurrence, a 10-year study","volume":"85","author":"Casenaz","year":"2022","journal-title":"J Infect"},{"key":"10.1016\/j.jiac.2026.103054_bib5","article-title":"Penetration of linezolid into bone tissue 24 h after administration in patients with multidrug-resistant spinal tuberculosis","volume":"14","author":"Li","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jiac.2026.103054_bib6","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jiac.2016.05.003","article-title":"A retrospective study of the risk factors for linezolid-induced thrombocytopenia and anemia","volume":"22","author":"Hanai","year":"2016","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2026.103054_bib7","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jiac.2018.01.010","article-title":"Efficacy, safety and pharmacokinetics of tedizolid versus linezolid in patients with skin and soft tissue infections in Japan - results of a randomised, multicentre phase 3 study","volume":"24","author":"Mikamo","year":"2018","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2026.103054_bib8","article-title":"Long-term use of tedizolid in osteoarticular infections: benefits among oxazolidinone drugs","volume":"10","author":"Benavent","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.jiac.2026.103054_bib9","doi-asserted-by":"crossref","first-page":"627","DOI":"10.5414\/CP204007","article-title":"Efficacy and safety of tedizolid in a patient with linezolid-induced neutropenia: a case report","volume":"59","author":"Kobayashi","year":"2021","journal-title":"Int J Clin Pharm Ther"},{"key":"10.1016\/j.jiac.2026.103054_bib10","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.jiac.2022.04.003","article-title":"Correction of thrombocytopenia caused by linezolid with scheduled sequential tedizolid use in patients with vertebral osteomyelitis by antibiotic resistant Gram-positive organisms","volume":"28","author":"Ueda","year":"2022","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2026.103054_bib11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40360-021-00479-w","article-title":"Proposal of initial and maintenance dosing regimens with linezolid for renal impairment patients","volume":"22","author":"Kawasuji","year":"2021","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.jiac.2026.103054_bib12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.5649\/jjphcs.37.335","article-title":"Development of software for antimicrobial PK\/PD simulation incorporating montecarlo simulation based on microsoft^|^reg; Office Excel","volume":"37","author":"Oda","year":"2011","journal-title":"Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)"},{"key":"10.1016\/j.jiac.2026.103054_bib13","article-title":"Tissue penetration of antimicrobials in intensive care unit patients: a systematic review-part I","volume":"11","author":"Finazzi","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.jiac.2026.103054_bib14","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1128\/AAC.02344-14","article-title":"Penetration of daptomycin into bone and synovial fluid in joint replacement","volume":"58","author":"Montange","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2026.103054_bib15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40780-022-00248-9","article-title":"Plasma and synovial fluid concentrations of linezolid in patients with knee osteoarthritis infected with Staphylococcus aureus","volume":"8","author":"Negishi","year":"2022","journal-title":"J Pharm Health Care Sci"},{"key":"10.1016\/j.jiac.2026.103054_bib16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40780-023-00303-z","article-title":"Synovial fluid and plasma concentrations of tedizolid in patients with osteoarthritis infected with Staphylococcus aureus effectively determined with fluorescence detection","volume":"9","author":"Negishi","year":"2023","journal-title":"J Pharm Health Care Sci"},{"key":"10.1016\/j.jiac.2026.103054_bib17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijid.2019.02.005","article-title":"Antibiotic penetration into bone and joints: an updated review","volume":"81","author":"Thabit","year":"2019","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jiac.2026.103054_bib18","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s40262-017-0601-x","article-title":"Clinical pharmacokinetics and pharmacodynamics of oxazolidinones","volume":"57","author":"Roger","year":"2018","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jiac.2026.103054_bib19","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/17425255.2017.1290080","article-title":"Pharmacokinetic drug evaluation of tedizolid for the treatment of skin infections","volume":"13","author":"McBride","year":"2017","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.jiac.2026.103054_bib20","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s13318-023-00836-6","article-title":"Monitoring salivary concentrations of tedizolid and linezolid using rats","volume":"48","author":"Inoue","year":"2023","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.jiac.2026.103054_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/cts.70100","article-title":"Penetration of linezolid and tedizolid in cerebrospinal fluid of mouse and impact of blood-brain barrier disruption","volume":"18","author":"Lahouati","year":"2025","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.jiac.2026.103054_bib22","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jsps.2019.09.002","article-title":"Determining therapeutic trough ranges for linezolid","volume":"27","author":"Alsultan","year":"2019","journal-title":"Saudi Pharm J"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X26001522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X26001522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T13:19:27Z","timestamp":1788527967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X26001522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1341321X26001522"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2026.103054","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical improvement of methicillin-resistant Staphylococcus epidermidis prosthetic knee joint infection after changing therapy from tedizolid to linezolid: A case report","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2026.103054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103054"}}